Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $82.3500 (-0.54%) ($81.1800 - $83.1400) on Fri. Feb. 18, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.1% (three month average) | RSI | 40 | Latest Price | $82.3500(-0.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -0.9% a day on average for past five trading days. | Weekly Trend | BAX declines -1.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(37%) VYM(35%) SPLV(34%) XLP(34%) SDY(33%) | Factors Impacting BAX price | BAX will decline at least -0.55% in a week (0% probabilities). VIXM(-22%) UUP(-22%) VXX(-1%) TBT(-1%) EDOC(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.55% (StdDev 1.1%) | Hourly BBV | -0.7 () | Intraday Trend | -0% | | | |
|
Resistance Level | $85.67 | 5 Day Moving Average | $84.26(-2.27%) | 10 Day Moving Average | $85.85(-4.08%) | 20 Day Moving Average | $85.67(-3.88%) | To recent high | -7.9% | To recent low | 10.4% | Market Cap | $42.014b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |